Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 2/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 3/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.37 |
| ▸ | AGXT | P21549 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9019164 | 1.00 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL2644673 | 0.90 | TSHR (0.48) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL6005456 | 0.81 | SLC1A3 (0.41) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL5566637 | 0.79 | RCE1 (0.51) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL12694282 | 0.79 | TSHR (0.44) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL6574317 | 0.78 | PPARG (0.42) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL6005459 | 0.78 | TSHR (0.45) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 | |
| SCHEMBL1412775 | 0.76 | ALDH1A1 (0.50) | CYP2D6ALDH1A1RECQLLTA4HLMNA | |
| SCHEMBL4904318 | 0.74 | TSHR (0.39) | MEN1KMT2ATSHRALDH1A1 | |
| SCHEMBL15366358 | 0.74 | TSHR (0.48) | SLC1A3SLC1A2SLC1A1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312474-A1 | ANTHRACYCLINS AND CONJUGATES THEREOF | SYNAFFIX B.V. (NL) | 2025-10-09 | — | — | US | disclosed |
| EP-4572798-A1 | ANTHRACYCLINS AND CONJUGATES THEREOF | Synaffix B.V. (NL) | 2025-06-25 | — | — | EP | disclosed |
| WO-2024038065-A1 | ANTHRACYCLINS AND CONJUGATES THEREOF | SYNAFFIX B.V. (NL) | 2024-02-22 | — | — | WO | disclosed |
| EP-0434960-B1 | Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates | PHARMACIA SPA (IT) | 1996-09-18 | — | — | EP | disclosed |
| US-5304687-A | 1-alkoxy-2,2*-diiodo-diethyl ether which reacts with doxorubicin to yield anthrocycline antibiotics | FARMITALIA CARLO ERBA S.R.L. (IT) | 1994-04-19 | — | — | US | disclosed |
| EP-0434960-A1 | Chiral 1,5-diiodo-2-methoxy or benzyloxy intermediates | PHARMACIA S.p.A. (IT) | 1991-07-03 | — | — | EP | disclosed |
| WO-1991009046-A1 | MORPHOLINYL DERIVATIVES OF DOXORUBICIN AND PROCESS FOR THEIR PREPARATION | FARMITALIA CARLO ERBA S.R.L. (IT) | 1991-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250312474-A1 | ANTHRACYCLINS AND CONJUGATES THEREOF | ANTXR2, NCL, DUT | SLC1A3 3339/4885SLC1A2 2736/4885SLC1A1 3191/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.